Intrinsic Value of S&P & Nasdaq Contact Us

Clene Inc. CLNN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
36/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$50.00
+649.1%

Clene Inc. (CLNN) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 7 Buy, 1 Hold.

The consensus price target is $50.00, representing an upside of 649.1% from the current price $6.68.

Analysts estimate Earnings Per Share (EPS) of $-4.45 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-5.67 vs est $-4.45 (missed -27.4%). 2025: actual $-2.65 vs est $-2.35 (missed -12.7%). Analyst accuracy: 84%.

CLNN Stock — 12-Month Price Forecast

$50.00
▲ +649.06% Upside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for Clene Inc., the price target is $50.00.
The average price target represents a +649.06% change from the last price of $6.68.

CLNN Analyst Ratings

Buy
8
Ratings
7 Buy
1 Hold
Based on 8 analysts giving stock ratings to Clene Inc. in the past 3 months
Rating breakdown
Buy
7 88%
Hold
1 13%
88%
Buy
7 analysts
13%
Hold
1 analysts
0%
Sell
0 analysts

EPS Estimates — CLNN

84%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$5.67 vs Est –$4.45 ▼ 21.5% off
2025 Actual –$2.65 vs Est –$2.35 ▼ 11.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — CLNN

82%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.000B vs Est $0.000B ▼ 5.8% off
2025 Actual $0.000B vs Est $0.000B ▲ 30.8% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message